You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peg-IFN

Showing 1 - 25 of 1,499
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Hepatitis B, Chronic Trial in Guangzhou (ASC42 10mg, ASC42 15mg, ih PEG-IFN a-2a)

Recruiting
  • Hepatitis B, Chronic
  • ASC42 10mg
  • +4 more
  • Guangzhou, Guangdong, China
    NanFang Hospital of Southern Medical University
Jan 13, 2022

Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)

Not yet recruiting
  • Hepatitis B, Chronic
  • Shanghai, Shanghai, China
    Shanghai Tong Ren Hospital
Nov 12, 2021

Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)

Recruiting
  • Adult T-cell Leukemia-Lymphoma
  • ATLL
  • Miami, Florida
    University of Miami
Jan 24, 2022

HIV, Hepatitis C Trial in United States (Ribavirin, Aldesleukin, Peginterferon alfa-2b)

Completed
  • HIV Infections
  • Hepatitis C
  • Los Angeles, California
  • +7 more
Oct 28, 2021

Chronic Hepatitis B Trial in Beijing (PEG-IFN)

Recruiting
  • Chronic Hepatitis B
  • PEG-IFN
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
May 9, 2022

Chronic Hepatitis B Trial in Beijing (PEG-IFN)

Recruiting
  • Chronic Hepatitis B
  • PEG-IFN
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
May 9, 2022

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Oct 1, 2021

Chronic Hepatitis C Trial (Danoprevir, Ritonavir, peginterferon alfa-2a)

Completed
Has Results
  • Chronic Hepatitis C
  • (no location specified)
Feb 28, 2021

Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • Shanghai, Shanghai, China
  • +1 more
Feb 16, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,

Recruiting
  • Chronic HBV Infection
  • Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
  • +2 more
  • Beijing, Beijing, China
  • +7 more
Feb 23, 2023

HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)

Unknown status
  • HIV
  • +2 more
  • Pegylated Interferon alpha 2b (peg-IFN-α2b)
  • 3BNC117 + 10-1074
  • Philadelphia, Pennsylvania
  • +1 more
Jun 22, 2021

Liver Fibrosis Trial (PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate, Tenofovir Disoproxil Fumarate)

Not yet recruiting
  • Liver Fibrosis
  • PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate
  • Tenofovir Disoproxil Fumarate
  • (no location specified)
Nov 17, 2020

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

Chronic Hepatitis B Trial in Guangzhou, Kunming, Shanghai (HPDCs-T immune therapy)

Completed
  • Chronic Hepatitis B
  • HPDCs-T immune therapy
  • Guangzhou, Guangdong, China
  • +2 more
Oct 28, 2020

Hepatitis B Trial in New Delhi (Peg IFN 2b)

Unknown status
  • Hepatitis B
  • Peg IFN 2b
  • New Delhi, Delhi, India
    Institute of Liver and Biliary Sciences
Feb 1, 2020

Chronic Viral Hepatitis B With Delta-agent Trial in Russian Federation (Myrcludex B, PEG IFN alfa-2a, Tenofovir)

Completed
Has Results
  • Chronic Viral Hepatitis B With Delta-agent
  • Myrcludex B
  • +2 more
  • Chelyabinsk, Russian Federation
  • +6 more
Apr 7, 2021

Hepatitis Delta Virus Trial in Worldwide (Lonafarnib, Ritonavir, PEG IFN-alfa-2a)

Recruiting
  • Hepatitis Delta Virus
  • Fresno, California
  • +117 more
Sep 30, 2021

Hepatitis C, Human Immunodeficiency Virus, HIV Trial in San Francisco (Pegylated interferon alfa-2a + Ribavirin)

Completed
Has Results
  • Hepatitis C
  • +2 more
  • Pegylated interferon alfa-2a + Ribavirin
  • San Francisco, California
    San Francisco General Hospital/UCSF
May 14, 2020

HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))

Completed
Has Results
  • HIV Infections
  • Hepatitis C
  • Pegylated-Interferon Alfa 2b (PEG-IFN)
  • +2 more
  • Birmingham, Alabama
  • +42 more
Nov 2, 2021